November 2, 2009: FDA Issues Safety Alert for Byetta

The FDA announced today that a labeling change has been made for Byetta (exenatide). 

Byetta is an injectable prescription drug.  It is used to control the level of glucose in the blood for patients with type 2 diabetes.  The drug is made by Amylin Pharmaceuticals Inc., which is based in San Diego, California. 

The safety alert warns medical professionals that kidney problems may occur if used under certain conditions.  These conditions include having prior risk factors that range from hypertension to urinary tract infection.    

To date, there have been 78 reported cases of patients having either renal failure or renal insufficiency. 

Adverse events that occur with the use of Byetta should be reported to the FDA’s MedWatch Adverse Event Reporting Program as follows:

• online at www.fda.gov/MedWatch/report.htm, 
• by phone (1-800-FDA-1088), 
• by returning the postage paid FDA form 3500 (which may be downloaded from www.fda.gov/MedWatch/getforms.htm) and mailing to MedWatch, 5600 Fishers Lane, Rockville, MD 20853-9787, or  
• by fax (1-800-FDA-0178)

For 25 years, the Law Firm of Eric H. Weinberg has helped hundreds of individuals injured by recalled drug products.  We are ready to help you.  If you believe that you have suffered an injury related to the use of Stamina-Rx, please click Free Legal Case Evaluation, or call us toll free at 1-877-934-6274.

HOME | OUR FIRM | OUR SUCCESSful cases | faq | contact us | Free Case Evaluation
DISCLAIMER | Privacy policy | terms of use | site map | links
Copyright Law Offices of Eric H. Weinberg ©2009 All Rights Reserved :: Web Design CT